These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 20145155)

  • 21. Proliferation of human glioblastoma stem cells occurs independently of exogenous mitogens.
    Kelly JJ; Stechishin O; Chojnacki A; Lun X; Sun B; Senger DL; Forsyth P; Auer RN; Dunn JF; Cairncross JG; Parney IF; Weiss S
    Stem Cells; 2009 Aug; 27(8):1722-33. PubMed ID: 19544433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dedifferentiation of patient-derived glioblastoma multiforme cell lines results in a cancer stem cell-like state with mitogen-independent growth.
    Olmez I; Shen W; McDonald H; Ozpolat B
    J Cell Mol Med; 2015 Jun; 19(6):1262-72. PubMed ID: 25787115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microenvironmental Modulation of Decorin and Lumican in Temozolomide-Resistant Glioblastoma and Neuroblastoma Cancer Stem-Like Cells.
    Farace C; Oliver JA; Melguizo C; Alvarez P; Bandiera P; Rama AR; Malaguarnera G; Ortiz R; Madeddu R; Prados J
    PLoS One; 2015; 10(7):e0134111. PubMed ID: 26230845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glioma cell populations grouped by different cell type markers drive brain tumor growth.
    Prestegarden L; Svendsen A; Wang J; Sleire L; Skaftnesmo KO; Bjerkvig R; Yan T; Askland L; Persson A; Sakariassen PØ; Enger PØ
    Cancer Res; 2010 Jun; 70(11):4274-9. PubMed ID: 20460538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens.
    Miki J; Furusato B; Li H; Gu Y; Takahashi H; Egawa S; Sesterhenn IA; McLeod DG; Srivastava S; Rhim JS
    Cancer Res; 2007 Apr; 67(7):3153-61. PubMed ID: 17409422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme.
    Pallini R; Ricci-Vitiani L; Banna GL; Signore M; Lombardi D; Todaro M; Stassi G; Martini M; Maira G; Larocca LM; De Maria R
    Clin Cancer Res; 2008 Dec; 14(24):8205-12. PubMed ID: 19088037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation.
    Kemper K; Sprick MR; de Bree M; Scopelliti A; Vermeulen L; Hoek M; Zeilstra J; Pals ST; Mehmet H; Stassi G; Medema JP
    Cancer Res; 2010 Jan; 70(2):719-29. PubMed ID: 20068153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.
    Botchkina IL; Rowehl RA; Rivadeneira DE; Karpeh MS; Crawford H; Dufour A; Ju J; Wang Y; Leyfman Y; Botchkina GI
    Cancer Genomics Proteomics; 2009; 6(1):19-29. PubMed ID: 19451087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycomic and transcriptomic response of GSC11 glioblastoma stem cells to STAT3 phosphorylation inhibition and serum-induced differentiation.
    He H; Nilsson CL; Emmett MR; Marshall AG; Kroes RA; Moskal JR; Ji Y; Colman H; Priebe W; Lang FF; Conrad CA
    J Proteome Res; 2010 May; 9(5):2098-108. PubMed ID: 20199106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endothelial cells induce cancer stem cell features in differentiated glioblastoma cells via bFGF.
    Fessler E; Borovski T; Medema JP
    Mol Cancer; 2015 Aug; 14():157. PubMed ID: 26282129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A novel adherent culture method of glioblastoma cells expressing CD133 using collagen-1-coated plates].
    Motegi H; Kamoshima Y; Terasaka S; Kobayashi H; Houkin K
    Hokkaido Igaku Zasshi; 2012 Aug; 87(4-5):147-51. PubMed ID: 23016266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma.
    Chiou SH; Yu CC; Huang CY; Lin SC; Liu CJ; Tsai TH; Chou SH; Chien CS; Ku HH; Lo JF
    Clin Cancer Res; 2008 Jul; 14(13):4085-95. PubMed ID: 18593985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MIR-451 and Imatinib mesylate inhibit tumor growth of Glioblastoma stem cells.
    Gal H; Pandi G; Kanner AA; Ram Z; Lithwick-Yanai G; Amariglio N; Rechavi G; Givol D
    Biochem Biophys Res Commun; 2008 Nov; 376(1):86-90. PubMed ID: 18765229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigating the link between molecular subtypes of glioblastoma, epithelial-mesenchymal transition, and CD133 cell surface protein.
    Zarkoob H; Taube JH; Singh SK; Mani SA; Kohandel M
    PLoS One; 2013; 8(5):e64169. PubMed ID: 23734191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of invasive properties of CD133+ glioblastoma stem cells: a role for MT1-MMP in bioactive lysophospholipid signaling.
    Annabi B; Lachambre MP; Plouffe K; Sartelet H; Béliveau R
    Mol Carcinog; 2009 Oct; 48(10):910-9. PubMed ID: 19326372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Down-expression of miR-154 suppresses tumourigenesis in CD133(+) glioblastoma stem cells.
    Yang L; Yan Z; Wang Y; Ma W; Li C
    Cell Biochem Funct; 2016 Aug; 34(6):404-13. PubMed ID: 27338789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma.
    Rappa G; Fodstad O; Lorico A
    Stem Cells; 2008 Dec; 26(12):3008-17. PubMed ID: 18802032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glioblastoma Multiforme Stem Cell Cycle Arrest by Alkylaminophenol Through the Modulation of EGFR and CSC Signaling Pathways.
    Doan P; Musa A; Murugesan A; Sipilä V; Candeias NR; Emmert-Streib F; Ruusuvuori P; Granberg K; Yli-Harja O; Kandhavelu M
    Cells; 2020 Mar; 9(3):. PubMed ID: 32164385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo investigation of CD133 as a putative marker of cancer stem cells in Hep-2 cell line.
    Wei XD; Zhou L; Cheng L; Tian J; Jiang JJ; Maccallum J
    Head Neck; 2009 Jan; 31(1):94-101. PubMed ID: 18853445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BRACHYURY confers cancer stem cell characteristics on colorectal cancer cells.
    Sarkar D; Shields B; Davies ML; Müller J; Wakeman JA
    Int J Cancer; 2012 Jan; 130(2):328-37. PubMed ID: 21365650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.